ArticleInternational cancer conference journal2024

Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer.

Takahiro Kirisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.